Fernando Doñate

University of Santa Monica — United States

Medicine · Health Sciences

25h-index3.2kcitations176works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal cell carcinoma treatment(58), Renal and related cancers(31), Cell Adhesion Molecules Research(20), Monoclonal and Polyclonal Antibodies Research(18), HER2/EGFR in Cancer Research(16)

Publications176 total

The Selective Estrogen Receptor Degrader ZN-c5 Has Broad Antitumor Activity in Wild-Type and Mutant ER-Positive Breast Cancer Models
Molecular Cancer Therapeutics·2025Open Access
Abstract 2153: Cyclin E1 protein overexpression sensitizes ovarian cancer cells to ZN-c3, a novel, selective and oral bioavailable inhibitor of Wee1
Cancer Research·2023· 3 cited
Data from Inhibition of Megakaryocyte Differentiation by Antibody–Drug Conjugates (ADCs) is Mediated by Macropinocytosis: Implications for ADC-induced Thrombocytopenia
2023Open Access
Supplemental data from A Potential Mechanism for ADC-Induced Neutropenia: Role of Neutrophils in Their Own Demise
2023Open Access
Supplementary methods, legends, Figures S1-S5, and Tables S1-S2 from Inhibition of Megakaryocyte Differentiation by Antibody–Drug Conjugates (ADCs) is Mediated by Macropinocytosis: Implications for ADC-induced Thrombocytopenia
2023Open Access
Supplementary Data from The Discovery and Preclinical Development of ASG-5ME, an Antibody–Drug Conjugate Targeting SLC44A4-Positive Epithelial Tumors Including Pancreatic and Prostate Cancer
2023Open Access
Data from A Potential Mechanism for ADC-Induced Neutropenia: Role of Neutrophils in Their Own Demise
2023Open Access
Supplemental data from A Potential Mechanism for ADC-Induced Neutropenia: Role of Neutrophils in Their Own Demise
2023Open Access
Data from AGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody–Drug Conjugate as a Potential Therapeutic for B/T-Cell Malignancies and AML: A New Role for CD37 in AML
2023Open Access
Supplementary Figures S1-S4 and Supplementary Methods from AGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody–Drug Conjugate as a Potential Therapeutic for B/T-Cell Malignancies and AML: A New Role for CD37 in AML
2023Open Access
Supplementary methods, legends, Figures S1-S5, and Tables S1-S2 from Inhibition of Megakaryocyte Differentiation by Antibody–Drug Conjugates (ADCs) is Mediated by Macropinocytosis: Implications for ADC-induced Thrombocytopenia
2023Open Access
Data from Inhibition of Megakaryocyte Differentiation by Antibody–Drug Conjugates (ADCs) is Mediated by Macropinocytosis: Implications for ADC-induced Thrombocytopenia
2023Open Access
Data from Development of ASG-15ME, a Novel Antibody–Drug Conjugate Targeting <i>SLITRK6</i>, a New Urothelial Cancer Biomarker
2023Open Access
Supplementary Materials and Methods: Generation of IHC Reagent M15-68(2)22 from Development of ASG-15ME, a Novel Antibody–Drug Conjugate Targeting <i>SLITRK6</i>, a New Urothelial Cancer Biomarker
2023Open Access
Data from Development of ASG-15ME, a Novel Antibody–Drug Conjugate Targeting <i>SLITRK6</i>, a New Urothelial Cancer Biomarker
2023Open Access
Supplementary Materials and Methods: Generation of IHC Reagent M15-68(2)22 from Development of ASG-15ME, a Novel Antibody–Drug Conjugate Targeting <i>SLITRK6</i>, a New Urothelial Cancer Biomarker
2023Open Access
Supplementary Figures S1-S4 and Supplementary Methods from AGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody–Drug Conjugate as a Potential Therapeutic for B/T-Cell Malignancies and AML: A New Role for CD37 in AML
2023Open Access
Data from AGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody–Drug Conjugate as a Potential Therapeutic for B/T-Cell Malignancies and AML: A New Role for CD37 in AML
2023Open Access
Supplementary Data from The Discovery and Preclinical Development of ASG-5ME, an Antibody–Drug Conjugate Targeting SLC44A4-Positive Epithelial Tumors Including Pancreatic and Prostate Cancer
2023Open Access
Data from A Potential Mechanism for ADC-Induced Neutropenia: Role of Neutrophils in Their Own Demise
2023Open Access
page 1 of 9Next →

Frequent Co-authors

Andrew P. Mazar(16), David R. Stover(11), Héctor Aviña(9), David E. Shaw(9), Pia M. Challita-Eid(8), Karen Morrison(8), Kendall Morrison(8), Zili An(7), Sher Karki(7), Daniel S. Pereira(7), Ingrid B.J. Joseph(7), Xiaojun Guan(7), Peng Yang(6), Linnette Capo(6), Faisal Malik(6), Jose C. Juarez(6), M L Plunkett(6), Keith R. McCrae(6), Alla Verlinsky(5), Banmeet S. Anand(5)